Literature DB >> 27248633

New Agents to Treat Chronic Lymphocytic Leukemia.

Harriet S Walter1, Gilles A Salles2, Martin J S Dyer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27248633     DOI： 10.1056/NEJMc1602674

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study.

Authors:  Yunsuk Choi; Jung-Hee Lee; Chul Won Jung; Jae-Cheol Jo; Jin Seok Kim; Inho Kim; Silvia Park; June-Won Cheong; Sang-Hyuk Park; Sung-Yong Kim; Hong-Ghi Lee
Journal:  Korean J Intern Med       Date:  2020-04-14       Impact factor: 2.884

2.  Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines.

Authors:  Ryohei Kozaki; Meike Vogler; Harriet S Walter; Sandrine Jayne; David Dinsdale; Reiner Siebert; Martin J S Dyer; Toshio Yoshizawa
Journal:  Cancers (Basel)       Date:  2018-04-23       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.